1,589
Participants
Start Date
November 30, 2009
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Telmisartan (Kinzal/Pritor, BAY68-9291)
Patients under daily life treatment receiving Pritor according to local drug information.
Many Locations
Lead Sponsor
International Clinical Trials Association
OTHER
Bayer
INDUSTRY